Connecticut’s quasi-public technology development and investment arm has taken under its wing a young Yale biotechnology prospect developing a surgical device.
NovaTract Surgical LLC of Guilford has enrolled in Connecticut Innovations Inc.’s pre-seed support services program.
Under the program, CI gives NovaTract support assessing its market and intellectual property, plus will provide connections to potential investors and other resources.
NovaTract also receives an unspecified amount of initial funding.
NovaTract’s device, used in tandem with an endoscope, would be inserted via a single-incision through the belly button or a natural body opening to access the abdominal cavity for gall bladder removals and appendectomies.
The device is based on research by Dr. Kurt E. Roberts, NovaTract’s co-founder and an assistant professor of gastrointestinal and general surgery at Yale University School of Medicine.
NovaTract co-founder and CEO Eleanor Tandler said having both Yale and CI has mentors “gives us the best chance of future success.”
